Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

YY1-MIR372-SQSTM1 regulatory axis in autophagy.

Feng L, Ma Y, Sun J, Shen Q, Liu L, Lu H, Wang F, Yue Y, Li J, Zhang S, Lin X, Chu J, Han W, Wang X, Jin H.

Autophagy. 2014 Aug;10(8):1442-53. doi: 10.4161/auto.29486. Epub 2014 Jun 11.

2.

Autophagy protein p62/SQSTM1 is involved in HAMLET-induced cell death by modulating apotosis in U87MG cells.

Zhang YB, Gong JL, Xing TY, Zheng SP, Ding W.

Cell Death Dis. 2013 Mar 21;4:e550. doi: 10.1038/cddis.2013.77.

3.

Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.

Tsang DP, Wu WK, Kang W, Lee YY, Wu F, Yu Z, Xiong L, Chan AW, Tong JH, Yang W, Li MS, Lau SS, Li X, Lee SD, Yang Y, Lai PB, Yu DY, Xu G, Lo KW, Chan MT, Wang H, Lee TL, Yu J, Wong N, Yip KY, To KF, Cheng AS.

J Pathol. 2016 Apr;238(5):651-64. doi: 10.1002/path.4688.

PMID:
26800240
4.

Polycomb YY1 is a critical interface between epigenetic code and miRNA machinery after exposure to hypoxia in malignancy.

Infante T, Mancini FP, Lanza A, Soricelli A, de Nigris F, Napoli C.

Biochim Biophys Acta. 2015 May;1853(5):975-86. doi: 10.1016/j.bbamcr.2015.01.009. Epub 2015 Jan 30.

5.

Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels.

Kim JH, Hong SK, Wu PK, Richards AL, Jackson WT, Park JI.

Exp Cell Res. 2014 Oct 1;327(2):340-52. doi: 10.1016/j.yexcr.2014.08.001. Epub 2014 Aug 14.

6.

Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis.

Wang AM, Huang TT, Hsu KW, Huang KH, Fang WL, Yang MH, Lo SS, Chi CW, Lin JJ, Yeh TS.

Oncotarget. 2014 Jul 15;5(13):5002-16.

7.

Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.

Samarasinghe B, Wales CT, Taylor FR, Jacobs AT.

Biochem Pharmacol. 2014 Feb 1;87(3):445-55. doi: 10.1016/j.bcp.2013.11.014. Epub 2013 Nov 28.

8.
9.

Q6, a novel hypoxia-targeted drug, regulates hypoxia-inducible factor signaling via an autophagy-dependent mechanism in hepatocellular carcinoma.

Liu XW, Cai TY, Zhu H, Cao J, Su Y, Hu YZ, He QJ, Yang B.

Autophagy. 2014 Jan;10(1):111-22. doi: 10.4161/auto.26838. Epub 2013 Nov 11.

10.

miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1.

Korkmaz G, le Sage C, Tekirdag KA, Agami R, Gozuacik D.

Autophagy. 2012 Feb 1;8(2):165-76. doi: 10.4161/auto.8.2.18351. Epub 2012 Feb 1.

PMID:
22248718
11.

A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma.

Yang Y, Zhou L, Lu L, Wang L, Li X, Jiang P, Chan LK, Zhang T, Yu J, Kwong J, Cheung TH, Chung T, Mak K, Sun H, Wang H.

Oncogene. 2013 Jul 18;32(29):3432-42. doi: 10.1038/onc.2012.360. Epub 2012 Aug 20.

PMID:
22907428
12.

microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.

Zhang N, Li X, Wu CW, Dong Y, Cai M, Mok MT, Wang H, Chen J, Ng SS, Chen M, Sung JJ, Yu J.

Oncogene. 2013 Oct 17;32(42):5078-88. doi: 10.1038/onc.2012.526. Epub 2012 Dec 3.

PMID:
23208495
13.

Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells.

Zou Z, Yuan Z, Zhang Q, Long Z, Chen J, Tang Z, Zhu Y, Chen S, Xu J, Yan M, Wang J, Liu Q.

Autophagy. 2012 Dec;8(12):1798-810. doi: 10.4161/auto.22110. Epub 2012 Oct 1.

14.

MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice.

Meenhuis A, van Veelen PA, de Looper H, van Boxtel N, van den Berge IJ, Sun SM, Taskesen E, Stern P, de Ru AH, van Adrichem AJ, Demmers J, Jongen-Lavrencic M, Löwenberg B, Touw IP, Sharp PA, Erkeland SJ.

Blood. 2011 Jul 28;118(4):916-25. doi: 10.1182/blood-2011-02-336487. Epub 2011 May 31.

15.

Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik.

Chen S, Zhou L, Zhang Y, Leng Y, Pei XY, Lin H, Jones R, Orlowski RZ, Dai Y, Grant S.

Mol Cell Biol. 2014 Sep 15;34(18):3435-49. doi: 10.1128/MCB.01383-13. Epub 2014 Jul 7.

16.

p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.

Kuo WL, Sharifi MN, Lingen MW, Ahmed O, Liu J, Nagilla M, Macleod KF, Cohen EE.

PLoS One. 2014 Mar 5;9(3):e90171. doi: 10.1371/journal.pone.0090171. eCollection 2014.

17.

SPBP is a sulforaphane induced transcriptional coactivator of NRF2 regulating expression of the autophagy receptor p62/SQSTM1.

Darvekar SR, Elvenes J, Brenne HB, Johansen T, Sjøttem E.

PLoS One. 2014 Jan 9;9(1):e85262. doi: 10.1371/journal.pone.0085262. eCollection 2014.

18.

Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent.

Parkhitko A, Myachina F, Morrison TA, Hindi KM, Auricchio N, Karbowniczek M, Wu JJ, Finkel T, Kwiatkowski DJ, Yu JJ, Henske EP.

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12455-60. doi: 10.1073/pnas.1104361108. Epub 2011 Jul 11.

19.

Functional interaction between sequestosome-1/p62 and autophagy-linked FYVE-containing protein WDFY3 in human osteoclasts.

Hocking LJ, Mellis DJ, McCabe PS, Helfrich MH, Rogers MJ.

Biochem Biophys Res Commun. 2010 Nov 19;402(3):543-8. doi: 10.1016/j.bbrc.2010.10.076. Epub 2010 Oct 29.

PMID:
20971078
20.

p62/SQSTM1 synergizes with autophagy for tumor growth in vivo.

Wei H, Wang C, Croce CM, Guan JL.

Genes Dev. 2014 Jun 1;28(11):1204-16. doi: 10.1101/gad.237354.113.

Supplemental Content

Support Center